Global Lung Cancer Surgery Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2029 |
 Market Size (Base Year) |
|
 Market Size (Forecast Year) |
USD 5.12 Billion |
 CAGR |
% |
| Major Markets Players |
|
>全球肺癌手术市场，按产品类型（手术器械、监测和可视化系统、内镜设备、机器人辅助胸外科系统等）、手术程序（开胸手术和微创手术）、患者类型（男性和女性）、最终用户（医院、门诊手术中心、学术和研究实验室、专科癌症护理中心等）、分销渠道（直接招标、零售销售、在线销售等）划分 - 行业趋势和预测到 2029 年。
肺癌手术市场分析与洞察
楔形手术是一种用于切除肺癌以及少量好组织的手术。肺段切除术是指切除较大部分的肺。肺叶切除术是切除五个肺叶之一的手术。全肺切除术是手术切除整个肺。
全球肺癌手术市场预计将在 2022 年至 2029 年的预测期内实现显著的市场增长。Data Bridge Market Research 分析称，在 2022 年至 2029 年的预测期内，该市场的复合年增长率为 5.5%，预计到 2029 年将达到 50.9207 亿美元。
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史岁月 |
2020（可定制 2019-2014） |
|
定量单位 |
收入（百万美元） |
|
涵盖的领域 |
按产品类型（手术器械、监测和可视化系统、内镜设备、机器人辅助胸外科系统等）、手术程序（开胸手术和微创手术）、患者类型（男性和女性）、最终用户（医院、门诊手术中心、学术和研究实验室、专科癌症护理中心等）、分销渠道（直接招标、零售、网上销售等） |
|
覆盖国家 |
美国、加拿大、墨西哥、德国、法国、英国、意大利、西班牙、荷兰、俄罗斯、比利时、瑞士、土耳其、欧洲其他地区、中国、日本、印度、韩国、澳大利亚、新加坡、泰国、马来西亚、印度尼西亚、菲律宾、亚太其他地区、巴西、阿根廷、秘鲁、南美洲其他地区、南非、沙特阿拉伯、阿联酋、埃及、以色列、中东和非洲其他地区 |
|
涵盖的市场参与者 |
AngioDynamics、Ackermann、Scanlan International、KLS Martin Group、Wexler Surgical、乐普医疗技术（北京）有限公司、Intuitive Surgical、FusionKraft、Surgical Holdings、GerMedUSA、Medtronic、Accuray Incorporated、Teleflex Incorporated、KARL STORZ SE & Co. KG、TROKAMED GmbH、Richard Wolf GmbH、Sontec Instruments, Inc.、asap endoscopic products GmbH、FUJIFILM Holdings America Corporation、Ambu A/S.、Johnson & Johnson Services, Inc、Olympus Corporation 等。 |
市场定义
根据肺癌的种类、位置和阶段以及其他医疗问题，某些人可能适合接受肺癌手术。这种手术用于治疗肺癌。它包括切除肿瘤、肿瘤周围的一些肺组织以及一些淋巴结。当肺癌有限且预计不会扩散时，手术切除肿瘤被认为是最佳选择。这包括类癌肿瘤和早期非小细胞肺癌。
肺癌手术市场动态
本节旨在了解市场驱动因素、优势、机遇、限制和挑战。以下内容将详细讨论所有这些内容：
驱动程序
- 肺癌患病率上升
肺癌是全球男性和女性最常见的死亡原因。由于烟草在发展中国家各个国家和人群中的流行，全球肺癌的发病率和死亡率不断上升。肺癌，包括气管癌和支气管癌，被广泛认为是对全球健康的威胁，给个人和家庭带来沉重的负担。肺癌是一种恶性肿瘤，其特征是肺部细胞组织不受控制地生长。它是男性和女性中第二常见的癌症，死亡率也是所有癌症中最高的。根据 GLOBOCAN 的数据，肺癌是全球最常见的恶性肿瘤，年龄标准化发病率为每 100,000 人年 22.5 例。男性患肺癌的几率高于女性。然而，自 20 世纪 90 年代中期以来，大多数发达国家男性患者的发病率有所下降，而女性患者的发病率则稳步上升。
- 医疗保健领域的技术进步
技术进步对肺癌手术至关重要。技术进步的重要性现已渗透到我们生活的方方面面。然而，最显著的好处来自于医疗保健领域的技术进步。通过开发新的治疗方法，卫生系统的技术变得更加有效。最近的技术进步挽救了数百万人的生命，提高了生活质量。
肺癌是所有年龄段人群中众所周知且普遍存在的疾病。尖端技术有助于提供更好的疾病筛查选择。因此，引进用于治疗肺癌的先进技术产品可以推动市场的增长
- 提高对益处的认识
非营利、私人和公共组织越来越多地开展肺癌宣传活动，推动市场增长。这些举措旨在减少耻辱和偏见、预防疾病和促进研究。
上述声明表明，随着不同组织开展了许多宣传活动，人们对肺癌的认识有所提高，人们知道如果在早期诊断出肺癌，肺癌是可以治愈的。因此，提高人们的认识是全球肺癌手术市场的驱动力。
机会
-
肺癌手术中微创技术的兴起
手术是早期非小细胞肺癌 (NSCLC) 的标准治疗方法。微创手术 (MIS) 现在比传统的开放手术更受欢迎。事实证明，电视辅助胸腔镜手术 (VATS) 和机器人辅助胸腔镜手术 (RATS) 等 MIS 手术可减少术后问题并缩短住院时间。因此，新的微创技术不断涌现。
对微创技术的需求不断增长也有利于进一步的经济增长和医疗保健行业的发展，而且它的主要成果是它显著影响了市场上更好、更先进的医疗技术的发展。因此，肺癌手术微创技术的激增为全球肺癌手术市场带来了更大的机会。
限制/挑战
然而，部分地区肺癌手术技术壁垒和肺癌手术费用高昂可能会阻碍肺癌手术的增长，从而阻碍市场的增长。此外，医疗技术行业的激烈竞争和海外资格认证的漫长准备时间可能是市场增长的挑战因素
本肺癌手术市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响，分析了新兴收入来源、市场法规变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新等方面的机会。如需了解有关肺癌手术市场的更多信息，请联系 Data Bridge Market Research 获取分析师简报，我们的团队将帮助您做出明智的市场决策，实现市场增长。
COVID-19 对肺癌手术市场的影响
包括医疗保健、医疗器械服务、汽车、制药等在内的所有行业都受到了新型冠状病毒的严重影响。此次疫情导致供应链中断和大规模制造业停工，对全球几乎每个国家的经济都产生了影响。非小细胞肺癌诊断行业也受到了此次疫情的影响。由于害怕感染病毒，患者选择呆在家里而不是接受诊断和治疗。随着病例的增加，医疗保健系统改变了对 COVID-19 的控制重点，从而推迟了癌症等其他慢性疾病的诊断和治疗。因此，预计疫情将对肺癌诊断行业产生负面影响。结果，COVID-19 患者占据了医院和诊所的所有可用床位，而肺癌患者受到的关注较少。此外，市场增长受到诊所可及性问题、社会排斥和人口封锁的影响，所有这些都减缓了转诊和患者流量。
然而，由于 COVID-19 病例略有缓解，肺癌手术市场可能会出现增长，这将导致肺癌诊断和手术需求增加，患者将前往诊所和医院接受治疗。COVID-19 病例数量正在下降，全球范围内针对该病毒的疫苗接种正在增加。
近期发展
- 2021 年 5 月，奥林巴斯今天宣布推出获得 FDA 510(k) 批准的 BF-UC190F 支气管内超声 (EBUS) 支气管镜，这是其强大的 EBUS 设备组合的最新成员，用于通过针刺活检进行微创肺癌诊断和分期。
全球肺癌手术市场范围
全球肺癌手术市场细分为产品类型、手术程序、患者类型、最终用户和分销渠道。这些细分市场之间的增长将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，以便做出战略决策，确定核心市场应用。
产品类型
- 手术器械
- 监控及可视化系统
- 内镜手术设备
- 机器人辅助胸外科手术系统
- 其他的
根据产品类型，全球肺癌手术市场分为手术器械、监测和可视化系统、内镜设备、机器人辅助胸外科手术系统等。
手术程序
- 开胸手术
- 微创手术
根据手术程序，全球肺癌手术市场分为开胸手术和微创手术。
患者类型
- 男性
- 女性
根据患者类型，全球肺癌手术市场分为男性和女性。
最终用户
- 医院
- 门诊及外科中心
- 学术及研究机构
- 专业癌症治疗中心
- 其他的
根据最终用户，全球肺癌手术市场分为医院、门诊和外科中心、学术和研究机构、专科癌症护理中心和其他。
分销渠道
- 直接招标
- 零售销售
- 网上销售
- 其他的
根据分销渠道，全球肺癌手术市场分为直接招标、零售、在线销售和其他。
肺癌手术市场区域分析/见解
对肺癌手术市场进行了分析，并按国家、产品类型、手术程序、患者类型、最终用户和分销渠道提供了市场规模洞察和趋势。
肺癌手术市场包括美国、加拿大、墨西哥、德国、法国、英国、意大利、西班牙、荷兰、俄罗斯、比利时、瑞士、土耳其、欧洲其他地区、中国、日本、印度、韩国、澳大利亚、新加坡、泰国、马来西亚、印度尼西亚、菲律宾、亚太其他地区、巴西、阿根廷、南美洲其他地区、南非、沙特阿拉伯、阿联酋、埃及、以色列以及中东和非洲其他地区。
就市场份额和市场收入而言，亚太地区在肺癌手术市场占据主导地位，并将在预测期内继续保持主导地位。中国在亚太地区占据主导地位，因为该国拥有先进的肺癌手术技术。这是由于该地区对肿瘤手术过程的验证和确认的需求不断增加，以及研究发展迅速。
报告的国家部分还提供了影响单个市场因素和市场法规变化的信息，这些因素和变化会影响市场的当前和未来趋势。新旧销售、国家人口统计、疾病流行病学和进出口关税等数据点是预测单个国家市场情况的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了全球品牌的存在和可用性以及它们因本土和国内品牌的激烈竞争而面临的挑战以及销售渠道的影响。
竞争格局和肺癌手术市场份额分析
肺癌手术市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与公司对肺癌手术市场的关注有关。
肺癌手术市场的一些主要参与者包括 AngioDynamics、Ackermann、Scanlan International、KLS Martin Group、Wexler Surgical、乐普医疗技术（北京）有限公司、Intuitive Surgical、FusionKraft、Surgical Holdings、GerMedUSA、Medtronic、Accuray Incorporated、Teleflex Incorporated、KARL STORZ SE & Co. KG、TROKAMED GmbH、Richard Wolf GmbH、Sontec Instruments, Inc.、asap endoscopic products GmbH、FUJIFILM Holdings America Corporation、Ambu A/S.、Johnson & Johnson Services, Inc、Olympus Corporation 等。
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、全球与区域和供应商份额分析。如有进一步询问，请要求分析师致电。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE GLOBAL LUNG CANCER SURGERY MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 MULTIVARIATE MODELLING
2.8 PRODUCT TYPE LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL
4.2 PORTER'S FIVE FORCES MODEL
5 EPIDEMIOLOGY
5.1 INCIDENCE OF LUNG CANCER, BY COUNTRY
5.2 TREATMENT RATE BY GENDER
5.3 MORTALITY BY GENDER
6 REGULATIONS OF THE GLOBAL LUNG CANCER SURGERY MARKET
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASED PREVALENCE OF LUNG CANCER DISEASES
7.1.2 TECHNOLOGICAL ADVANCEMENTS IN THE FIELD OF HEALTHCARE
7.1.3 INCREASED AWARENESS REGARDING THE BENEFITS
7.1.4 GOVERNMENT INITIATIVES TO IMPLEMENT SCREENING PROGRAMS FOR VARIOUS DISEASES
7.1.5 RISE IN AIR POLLUTION AND SURGE IN SMOKING
7.2 RESTRAINTS
7.2.1 HIGH COST OF LUNG CANCER SURGERY
7.2.2 INSUFFICIENT FUNDING FOR CANCER AND ASSOCIATED DISORDERS
7.2.3 STRINGENT REGULATORY FRAMEWORKS
7.3 OPPORTUNITIES
7.3.1 RISE OF MINIMALLY INVASIVE TECHNIQUES IN LUNG CANCER SURGERY
7.3.2 STRATEGIC INITIATIVES OF KEY PLAYERS
7.3.3 INCREASE IN RESEARCH AND DEVELOPMENT EFFORTS IN THE HEALTHCARE INDUSTRY
7.4 CHALLENGES
7.4.1 DEARTH OF SKILLED ONCOLOGISTS
7.4.2 HEALTH RISK OF LUNG CANCER SURGERIES
8 GLOBAL LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 SURGICAL INSTRUMENTS
8.2.1 HAND INSTRUMENTS
8.2.1.1 STAPLER
8.2.1.2 FORCEPS
8.2.1.3 ELECTRIC HOOK
8.2.1.4 RETRACTORS
8.2.1.5 CLAMPS
8.2.1.6 SCISSORS
8.2.1.7 ELEVATORS
8.2.1.8 HEMOCLIP APPLIERS
8.2.1.9 ULTRASOUND SCALPEL
8.2.1.10 RIB SHEARS
8.2.1.11 CUTTERS
8.2.1.12 NEEDLE HOLDER
8.2.1.13 TROCAR
8.2.1.14 OTHERS
8.2.2 POWERED SURGICAL EQUIPMENT
8.2.2.1 ADVANCED ENERGY INSTRUMENTS
8.2.2.1.1 ADVANCED BIPOLAR INSTRUMENTS
8.2.2.1.2 OTHERS
8.2.2.2 BASIC ENERGY INSTRUMENTS
8.2.2.2.1 BIPOLAR INSTRUMENTS
8.2.2.2.2 MONOPOLAR INSTRUMENTS
8.3 MONITORING & VISUALISING SYSTEM
8.3.1 CAMERAS & VIDEO SUPPORT
8.3.2 BRONCHOSCOPES
8.3.3 ENDOSCOPIC TROCARS WITH OPTICAL VIEWS
8.3.4 THORACOSCOPES
8.3.5 MEDIASTINOSCOPES
8.3.6 OTHERS
8.4 ENDOSURGICAL EQUIPMENTS
8.5 ROBOTIC ASSISTED SURGERY SYSTEMS
8.6 OTHERS
9 GLOBAL LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE
9.1 OVERVIEW
9.2 THORACOTOMY
9.2.1 LOBECTOMY
9.2.1.1 SURGICAL INSTRUMENTS
9.2.1.2 MONITORING & VISUALISING SYSTEMS
9.2.1.3 ENDOSURGICAL EQUIPMENT
9.2.1.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS
9.2.1.5 OTHERS
9.2.2 SLEEVE RESECTION
9.2.2.1 SURGICAL INSTRUMENTS
9.2.2.2 MONITORING & VISUALISING SYSTEMS
9.2.2.3 ENDOSURGICAL EQUIPMENT
9.2.2.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS
9.2.2.5 OTHERS
9.2.3 SEGMENTECTOMY
9.2.3.1 SURGICAL INSTRUMENTS
9.2.3.2 MONITORING & VISUALISING SYSTEMS
9.2.3.3 ENDOSURGICAL EQUIPMENT
9.2.3.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS
9.2.3.5 OTHERS
9.2.4 PNEUMONECTOMY
9.2.4.1 SURGICAL INSTRUMENTS
9.2.4.2 MONITORING & VISUALISING SYSTEMS
9.2.4.3 ENDOSURGICAL EQUIPMENT
9.2.4.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS
9.2.4.5 OTHERS
9.2.5 OTHERS
9.3 MINIMALLY INVASIVE SURGERIES
9.3.1 VIDEO-ASSISTED THORACIC SURGERY (VATS)
9.3.1.1 SURGICAL INSTRUMENTS
9.3.1.2 MONITORING & VISUALISING SYSTEMS
9.3.1.3 ENDOSURGICAL EQUIPMENT
9.3.1.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS
9.3.1.5 OTHERS
9.3.2 ROBOTICALLY-ASSISTED THORACIC SURGERY (RATS)
9.3.2.1 SURGICAL INSTRUMENTS
9.3.2.2 MONITORING & VISUALISING SYSTEMS
9.3.2.3 ENDOSURGICAL EQUIPMENT
9.3.2.4 ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS
9.3.2.5 OTHERS
10 GLOBAL LUNG CANCER SURGERY MARKET, BY PATIENT TYPE
10.1 OVERVIEW
10.2 MALE
10.2.1 GERIATRIC
10.2.1.1 THORACOTOMY
10.2.1.2 MINIMALLY INVASIVE SURGERIES
10.2.2 ADULTS
10.2.2.1 THORACOTOMY
10.2.2.2 MINIMALLY INVASIVE SURGERIES
10.2.3 PEDIATRIC
10.2.3.1 THORACOTOMY
10.2.3.2 MINIMALLY INVASIVE SURGERIES
10.3 FEMALE
10.3.1 GERIATRIC
10.3.1.1 THORACOTOMY
10.3.1.2 MINIMALLY INVASIVE SURGERIES
10.3.2 ADULTS
10.3.2.1 THORACOTOMY
10.3.2.2 MINIMALLY INVASIVE SURGERIES
10.3.3 PEDIATRIC
10.3.3.1 THORACOTOMY
10.3.3.2 MINIMALLY INVASIVE SURGERIES
11 GLOBAL LUNG CANCER SURGERY MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 RETAIL SALES
11.4 ONLINE SALES
11.5 OTHERS
12 GLOBAL LUNG CANCER SURGERY MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS
12.2.1 PUBLIC HOSPITALS
12.2.2 PRIVATE HOSPITALS
12.3 AMBULATORY SURGICAL CENTERS
12.4 SPECIALTY CANCER CARE CENTERS
12.5 ACADEMIC AND RESEARCH LABORATORIES
12.6 OTHERS
13 GLOBAL LUNG CANCER SURGERY MARKET, BY REGION
13.1 OVERVIEW
13.2 NORTH AMERICA
13.2.1 U.S
13.2.2 CANADA
13.2.3 MEXICO
13.3 EUROPE
13.3.1 GERMANY
13.3.2 FRANCE
13.3.3 U.K.
13.3.4 ITALY
13.3.5 SPAIN
13.3.6 RUSSIA
13.3.7 TURKEY
13.3.8 BELGIUM
13.3.9 NETHERLANDS
13.3.10 SWITZERLAND
13.3.11 REST OF EUROPE
13.4 ASIA-PACIFIC
13.4.1 CHINA
13.4.2 JAPAN
13.4.3 INDIA
13.4.4 SOUTH KOREA
13.4.5 AUSTRALIA
13.4.6 SINGAPORE
13.4.7 THAILAND
13.4.8 MALAYSIA
13.4.9 INDONESIA
13.4.10 PHILIPPINES
13.4.11 REST OF ASIA-PACIFIC
13.5 SOUTH AMERICA
13.5.1 BRAZIL
13.5.2 ARGENTINA
13.5.3 REST OF SOUTH AMERICA
13.6 MIDDLE EAST AND AFRICA
13.6.1 SAUDI ARABIA
13.6.2 SOUTH AFRICA
13.6.3 UAE
13.6.4 ISRAEL
13.6.5 EGYPT
13.6.6 REST OF MIDDLE EAST AND AFRICA
14 GLOBAL LUNG CANCER SURGERY MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: GLOBAL
14.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
14.3 COMPANY SHARE ANALYSIS: EUROPE
14.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
15 SWOT ANALYSIS
16 COMPANY PROFILES
16.1 JOHNSON & JOHNSON SERVICES, INC.
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENTS
16.2 ACCURAY INCORPORATED
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 PRODUCT PORTFOLIO
16.2.5 RECENT DEVELOPMENTS
16.3 INTUITIVE SURGICAL
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 PRODUCT PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 FUJIFILM HOLDINGS CORPORATION
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 PRODUCT PORTFOLIO
16.4.5 RECENT DEVELOPMENTS
16.5 AMBU A/S.
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENTS
16.6 ANGIODYNAMICS
16.6.1 COMPANY SNAPSHOT
16.6.2 REVENUE ANALYSIS
16.6.3 PRODUCT PORTFOLIO
16.6.4 RECENT DEVELOPMENT
16.7 ACKERMANN
16.7.1 COMPANY SNAPSHOT
16.7.2 PRODUCT PORTFOLIO
16.7.3 RECENT DEVELOPMENTS
16.8 ASAP ENDOSCOPIC PRODUCTS GMBH
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCTPORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 FUSIONKRAFT
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENTS
16.1 GERMED USA
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENTS
16.11 KLS MARTIN GROUP
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENTS
16.12 KARL STORZ SE & CO. KG
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENT
16.13 LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENT
16.14 MEDTRONICS (2021)
16.14.1 COMPANY SNAPSHOT
16.14.2 REVENUE ANALYSIS
16.14.3 PRODUCT PORTFOLIO
16.14.4 RECENT DEVELOPMENT
16.15 OLYMPUS CORPORATION
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCTPORTFOLIO
16.15.4 RECENT DEVELOPMENTS
16.16 RICHARD WOLF GMBH.
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENTS
16.17 SURGICAL HOLDINGS
16.17.1 COMPANY SNAPSHOT
16.17.2 PRODUCT PORTFOLIO
16.17.3 RECENT DEVELOPMENTS
16.18 SONTEC INSTRUMENTS, INC.
16.18.1 COMPANY SNAPSHOT
16.18.2 PRODUCT PORTFOLIO
16.18.3 RECENT DEVELOPMENT
16.19 SCANLAN INTERNATIONAL
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENTS
16.2 TELEFLEX INCORPORATED
16.20.1 COMPANY SNAPSHOT
16.20.2 REVENUE ANALYSIS
16.20.3 PRODUCTPORTFOLIO
16.20.4 RECENT DEVELOPMENT
16.21 TROKAMED GMBH.
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENT
16.22 WEXLER SURGICAL
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
表格列表
TABLE 1 THE BELOW TABLE SHOWS REGION-SPECIFIC INCIDENCE AGE-STANDARDIZED RATES PER 100,000 BY SEX FOR LUNG CANCER AMONG MEN AND WOMEN IN 2020
TABLE 2 GLOBAL LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 3 GLOBAL SURGICAL INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 4 GLOBAL SURGICAL INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 5 GLOBAL HAND INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 6 GLOBAL HAND INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME IN THOUSAND UNITS)
TABLE 7 GLOBAL POWERED SURGICAL EQUIPMENTS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 8 GLOBAL ADVANCED ENERGY INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 9 GLOBAL BASIC ENERGY INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 10 GLOBAL BASIC ENERGY INSTRUMENTS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (VOLUME IN THOUSAND UNITS)
TABLE 11 GLOBAL MONITORING & VISUALISING SYSTEMS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 12 GLOBAL MONITORING & VISUALISING SYSTEMS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 13 GLOBAL MONITORING & VISUALISING SYSTEMS IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (VOLUME IN THOUSAND UNITS)
TABLE 14 GLOBAL ENDOSURGICAL EQUIPMENT IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 15 GLOBAL ROBOTIC-ASSISTED THORACIC SURGERY SYSTEMS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 GLOBAL OTHERS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 GLOBAL LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 18 GLOBAL THORACOTOMY IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 GLOBAL THORACOTOMY IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 20 GLOBAL LOBECTOMY IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 21 GLOBAL SLEEVE RESECTION IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 22 GLOBAL SEGMENTECTOMY IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 23 GLOBAL PNEUMONECTOMY IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 24 GLOBAL MINIMALLY INVASIVE SURGERIES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 GLOBAL MINIMALLY INVASIVE SURGERIES IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 26 GLOBAL VIDEO-ASSISTED THORACIC SURGERY (VATS) IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 27 GLOBAL ROBOTICALLY-ASSISTED THORACIC SURGERY (RATS) IN LUNG CANCER SURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 28 GLOBAL LUNG CANCER SURGERY MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)
TABLE 29 GLOBAL MALE IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 30 GLOBAL MALE IN LUNG CANCER SURGERY MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)
TABLE 31 GLOBAL GERIATRIC IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 32 GLOBAL ADULTS IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 33 GLOBAL PEDIATRIC IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 34 GLOBAL FEMALE IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 GLOBAL FEMALE IN LUNG CANCER SURGERY MARKET, BY PATIENT TYPE, 2020-2029 (USD MILLION)
TABLE 36 GLOBAL GERIATRIC IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 37 GLOBAL ADULTS IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 38 GLOBAL PEDIATRIC IN LUNG CANCER SURGERY MARKET, BY SURGICAL PROCEDURE, 2020-2029 (USD MILLION)
TABLE 39 GLOBAL LUNG CANCER SURGERY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 40 GLOBAL DIRECT TENDER IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 41 GLOBAL RETAIL SALES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 42 GLOBAL ONLINE SALES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 43 GLOBAL ONLINE SALES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 44 GLOBAL LUNG CANCER SURGERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 45 GLOBAL HOSPITALS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 46 GLOBAL HOSPITALS IN LUNG CANCER SURGERY MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 47 GLOBAL AMBULATORY SURGICAL CENTERS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 48 GLOBAL SPECIALTY CANCER CARE CENTERS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 49 GLOBAL ACADEMIC AND RESEARCH LABORATORIES IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION))
TABLE 50 GLOBAL OTHERS IN LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 51 GLOBAL LUNG CANCER SURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 52 NORTH AMERICA LUNG CANCER SURGERY MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 53 EUROPE LUNG CANCER SURGERY MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 54 ASIA-PACIFIC LUNG CANCER SURGERY MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 55 SOUTH AMERICA LUNG CANCER SURGERY MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 56 MIDDLE EAST AND AFRICA LUNG CANCER SURGERY MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
图片列表
FIGURE 1 GLOBAL LUNG CANCER SURGERYMARKET: SEGMENTATION
FIGURE 2 GLOBAL LUNG CANCER SURGERY MARKET: GEOGRAPHIC SCOPE
FIGURE 3 GLOBAL LUNG CANCER SURGERYMARKET: DATA TRIANGULATION
FIGURE 4 GLOBAL LUNG CANCER SURGERY MARKET: SNAPSHOT
FIGURE 5 GLOBAL LUNG CANCER SURGERY MARKET: BOTTOM UP APPROACH
FIGURE 6 GLOBAL LUNG CANCER SURGERY MARKET: TOP DOWN APPROACH
FIGURE 7 GLOBAL LUNG CANCER SURGERY MARKET: INTERVIEWS BY REGION AND DESIGNATION
FIGURE 8 GLOBAL LUNG CANCER SURGERY MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GLOBAL LUNG CANCER SURGERY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL LUNG CANCER SURGERY MARKET: END USER COVERAGE GRID
FIGURE 11 GLOBAL LUNG CANCER SURGERY MARKET SEGMENTATION
FIGURE 12 GROWING PREVALENCE OF CANCER DISEASES, RISE IN AIR POLLUTION, AND SURGE IN SMOKING HABIT IS EXPECTED TO DRIVE THE GLOBAL LUNG CANCER SURGERY MARKET GROWTH IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 13 SURGICAL INSTRUMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL LUNG CANCER SURGERY MARKET IN 2022 & 2029
FIGURE 14 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE LUNG CANCER SURGERY MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE INCREASING WITH A STRONG CAGR IN THE FORECAST PERIOD FROM 2022 TO 2029
FIGURE 15 NORTH AMERICA IS THE MAXIMUM GROWING AND MOST PROFITABLE REVENUE POCKET FOR THE GLOBAL LUNG CANCER SURGERY MARKET IN THE FORECAST PERIOD FROM 2022 TO 2029
FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLOBAL LUNG CANCER SURGERY MARKET
FIGURE 17 GLOBAL LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, 2021
FIGURE 18 GLOBAL LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, 2022-2029 (USD MILLION)
FIGURE 19 GLOBAL LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, CAGR (2022-2029)
FIGURE 20 GLOBAL LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 21 GLOBAL LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, 2021
FIGURE 22 GLOBAL LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, 2022-2029 (USD MILLION)
FIGURE 23 GLOBAL LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, CAGR (2022-2029)
FIGURE 24 GLOBAL LUNG CANCER SURGERY MARKET: BY SURGICAL PROCEDURE, LIFELINE CURVE
FIGURE 25 GLOBAL LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, 2021
FIGURE 26 GLOBAL LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, 2022-2029 (USD MILLION)
FIGURE 27 GLOBAL LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, CAGR (2022-2029)
FIGURE 28 GLOBAL LUNG CANCER SURGERY MARKET: BY PATIENT TYPE, LIFELINE CURVE
FIGURE 29 GLOBAL LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 30 GLOBAL LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 31 GLOBAL LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 32 GLOBAL LUNG CANCER SURGERY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 33 GLOBAL LUNG CANCER SURGERY MARKET: BY END USER, 2021
FIGURE 34 GLOBAL LUNG CANCER SURGERY MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 35 GLOBAL LUNG CANCER SURGERY MARKET: BY END USER, CAGR (2022-2029)
FIGURE 36 GLOBAL LUNG CANCER SURGERY MARKET: BY END USER, LIFELINE CURVE
FIGURE 37 GLOBAL LUNG CANCER SURGERY MARKET: SNAPSHOT (2021)
FIGURE 38 GLOBAL LUNG CANCER SURGERY MARKET: BY REGION (2021)
FIGURE 39 GLOBAL LUNG CANCER SURGERY MARKET: BY REGION (2022 & 2029)
FIGURE 40 GLOBAL LUNG CANCER SURGERY MARKET: BY REGION (2021 & 2029)
FIGURE 41 GLOBAL LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 42 NORTH AMERICA LUNG CANCER SURGERY MARKET: SNAPSHOT (2021)
FIGURE 43 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2021)
FIGURE 44 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2022 & 2029)
FIGURE 45 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2021 & 2029)
FIGURE 46 NORTH AMERICA LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 47 EUROPE LUNG CANCER SURGERY MARKET: SNAPSHOT (2021)
FIGURE 48 EUROPE LUNG CANCER SURGERY MARKET: BY COUNTRY (2021)
FIGURE 49 EUROPE LUNG CANCER SURGERY MARKET: BY COUNTRY (2022 & 2029)
FIGURE 50 EUROPE LUNG CANCER SURGERY MARKET: BY COUNTRY (2021 & 2029)
FIGURE 51 EUROPE LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 52 ASIA-PACIFIC LUNG CANCER SURGERY MARKET: SNAPSHOT (2021)
FIGURE 53 ASIA-PACIFIC LUNG CANCER SURGERY MARKET: BY COUNTRY (2021)
FIGURE 54 ASIA-PACIFIC LUNG CANCER SURGERY MARKET: BY COUNTRY (2022 & 2029)
FIGURE 55 ASIA-PACIFIC LUNG CANCER SURGERY MARKET: BY COUNTRY (2021 & 2029)
FIGURE 56 ASIA-PACIFIC LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 57 SOUTH AMERICA LUNG CANCER SURGERY MARKET: SNAPSHOT (2021)
FIGURE 58 SOUTH AMERICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2021)
FIGURE 59 SOUTH AMERICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2022 & 2029)
FIGURE 60 SOUTH AMERICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2021 & 2029)
FIGURE 61 SOUTH AMERICA LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 62 MIDDLE EAST AND AFRICA LUNG CANCER SURGERY MARKET: SNAPSHOT (2021)
FIGURE 63 MIDDLE EAST AND AFRICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2021)
FIGURE 64 MIDDLE EAST AND AFRICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2022 & 2029)
FIGURE 65 MIDDLE EAST AND AFRICA LUNG CANCER SURGERY MARKET: BY COUNTRY (2021 & 2029)
FIGURE 66 MIDDLE EAST AND AFRICA LUNG CANCER SURGERY MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 67 GLOBAL LUNG CANCER SURGERY MARKET: COMPANY SHARE 2021 (%)
FIGURE 68 NORTH AMERICA LUNG CANCER SURGERY MARKET: COMPANY SHARE 2021 (%)
FIGURE 69 EUROPE LUNG CANCER SURGERY MARKET: COMPANY SHARE 2021 (%)
FIGURE 70 ASIA-PACIFIC LUNG CANCER SURGERY MARKET: COMPANY SHARE 2021 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
